Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

Gerda Trutnovsky; Olaf Reich; EA Joura; Magdalena Holter; A Ciresa-König; A Widschwendter; C Schauer; G Bogner; Z Jan; Angelika Boandl; MS Kalteis; Sigrid Regauer; Karl Tamussino

doi:10.1016/S0140-6736(22)00469-X

Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

Gerda Trutnovsky^* (First author)
, Olaf Reich
, EA Joura
, Magdalena Holter
, A Ciresa-König
, A Widschwendter
, C Schauer
, G Bogner
, Z Jan
, Angelika Boandl
, MS Kalteis
, Sigrid Regauer
, Karl Tamussino (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Research article

49 Citations (Web of Science)

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(22)00469-X
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

101 Mathematics
102 Computer Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine
305 Other Human Medicine, Health Sciences
501 Psychology

Research Fields

Cancer Research

DOI

10.1016/S0140-6736(22)00469-X

Links

Cite this

Trutnovsky, G., Reich, O., Joura, EA., Holter, M., Ciresa-König, A., Widschwendter, A., Schauer, C., Bogner, G., Jan, Z., Boandl, A., Kalteis, MS., Regauer, S., & Tamussino, K. (2022). Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial. The Lancet. https://doi.org/10.1016/S0140-6736(22)00469-X

@article{ccd510a59b494110a4e225983d651b1f,

title = "Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.",

author = "Gerda Trutnovsky and Olaf Reich and EA Joura and Magdalena Holter and A Ciresa-K{\"o}nig and A Widschwendter and C Schauer and G Bogner and Z Jan and Angelika Boandl and MS Kalteis and Sigrid Regauer and Karl Tamussino",

year = "2022",

doi = "10.1016/S0140-6736(22)00469-X",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial.

AU - Reich, Olaf

AU - Joura, EA

AU - Holter, Magdalena

AU - Ciresa-König, A

AU - Widschwendter, A

AU - Schauer, C

AU - Bogner, G

AU - Jan, Z

AU - Boandl, Angelika

AU - Kalteis, MS

AU - Regauer, Sigrid

A2 - Trutnovsky, Gerda

A2 - Tamussino, Karl

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000806825600021

UR - https://pubmed.ncbi.nlm.nih.gov/35483400

U2 - 10.1016/S0140-6736(22)00469-X

DO - 10.1016/S0140-6736(22)00469-X

M3 - Research article

C2 - 35483400

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -